Whalestream has ceased operations permanently
Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 07/17/2026 | CALL | $25.00 | 56,001 | +31,000 | +124.00% |
| 07/17/2026 | PUT | $25.00 | 56,001 | +31,000 | +124.00% |
| 07/09/2026 | CALL | $26.00 | 20,000 | +20,000 | |
| 07/09/2026 | PUT | $26.00 | 20,000 | +20,000 | |
| 08/21/2026 | CALL | $26.00 | 40,615 | +5,762 | +16.53% |
| 07/17/2026 | CALL | $25.00 | 20,516 | +5,494 | +36.57% |
| 07/10/2026 | PUT | $26.00 | 157 | -138 | -46.78% |
| 01/15/2027 | CALL | $30.00 | 55,819 | -151 | -0.27% |
| 07/17/2026 | CALL | $27.00 | 17,159 | -161 | -0.93% |
| 07/02/2026 | PUT | $25.50 | 36 | -177 | -83.10% |
| 01/15/2027 | CALL | $27.00 | 53,551 | -253 | -0.47% |
| 07/02/2026 | PUT | $25.00 | 3,192 | -302 | -8.64% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
| Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
| Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
| Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
| SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
| American Balanced Fund | 1.00% | 56.61M | 2.04B |
| Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
| iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
| Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
| Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
3 High-Yield Dividend Stocks Paying 5% or More That Are Worth Buying Now
07/12 03:25 am
The Motley Fool
Read moreNCLA to Fifth Circuit: Revive Suit Against Gov’t-Led Censorship of Covid Vaccine-Injured Americans
07/08 06:38 pm
GlobeNewswire Inc.
Read moreBBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
07/08 07:28 am
The Motley Fool
Read more2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now
07/07 06:30 pm
The Motley Fool
Read moreTransthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider
07/07 06:42 am
GlobeNewswire Inc.
Read moreMeet the 4 S&P 500 Dividend Stocks That Yield at Least 6%. Here's My Strongest Buy of the Bunch in July.
07/06 08:37 am
The Motley Fool
Read moreModerna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
07/03 11:14 am
The Motley Fool
Read moreWall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.
07/02 06:33 am
The Motley Fool
Read moreBig Pharma Has a Case of Merger Mania
06/30 12:26 am
The Motley Fool
Read moreAbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
06/29 11:21 am
The Motley Fool
Read moreA CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock?
06/28 04:30 am
The Motley Fool
Read moreOpinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
06/27 03:15 pm
The Motley Fool
Read moreAn Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?
06/25 11:18 am
The Motley Fool
Read moreOblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
06/25 06:00 am
GlobeNewswire Inc.
Read more2 High-Yield Dividend Stocks to Buy and Hold for a Decade
06/23 04:30 pm
The Motley Fool
Read moreCould Pfizer Stock Be Your Ticket to Generational Wealth?
06/21 09:15 pm
The Motley Fool
Read moreWant to Retire on $500,000? 3 Stocks to Buy and Never Sell
06/21 04:24 am
The Motley Fool
Read morePfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?
06/20 05:15 pm
The Motley Fool
Read moreStock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook
06/18 07:09 pm
The Motley Fool
Read moreFDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens
06/18 11:29 am
Benzinga
Read moreBio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors
06/15 04:00 am
GlobeNewswire Inc.
Read moreHow Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
06/13 06:15 pm
The Motley Fool
Read morePfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About
06/12 12:32 pm
The Motley Fool
Read moreValue Investors Question SpaceX's Record IPO: 'It's The Future That Kills You'
06/12 10:57 am
Benzinga
Read moreBristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.
06/11 02:02 pm
The Motley Fool
Read morePatent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
06/11 01:18 pm
Investing.com
Read moreMetastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
06/10 01:00 pm
GlobeNewswire Inc.
Read morePfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study
06/08 02:06 pm
Benzinga
Read more3 Dividend Stocks to Buy Hand Over Fist in June
06/07 01:30 am
The Motley Fool
Read moreCan Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.
06/06 01:32 pm
The Motley Fool
Read morePfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems
06/06 12:15 pm
The Motley Fool
Read moreArvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
06/04 08:00 am
GlobeNewswire Inc.
Read moreBetter High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?
06/04 02:30 am
The Motley Fool
Read moreLevicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026
06/03 04:00 am
GlobeNewswire Inc.
Read moreWhy Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks
06/01 11:15 pm
The Motley Fool
Read moreAbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
06/01 02:19 pm
The Motley Fool
Read moreCRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking
06/01 12:30 pm
The Motley Fool
Read moreWhy Wall Street Is Dead Wrong About This Popular Stock
05/30 03:15 pm
The Motley Fool
Read moreBay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants
05/28 02:00 pm
GlobeNewswire Inc.
Read moreThis Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe?
05/25 05:15 pm
The Motley Fool
Read moreTacrolimus Market Research Report 2026: Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2035
05/25 05:31 am
GlobeNewswire Inc.
Read moreEli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know.
05/25 05:05 am
The Motley Fool
Read moreIs Relay Therapeutics a Buy After Promising Trial Results?
05/22 05:30 pm
The Motley Fool
Read moreThe Most Important Healthcare Stock You're Not Watching
05/22 05:15 pm
The Motley Fool
Read moreThe Most Undervalued Healthcare Stock in the S&P 500 Right Now
05/21 07:05 am
The Motley Fool
Read moreESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight
05/20 01:00 pm
GlobeNewswire Inc.
Read morePfizer Expands Pneumococcal Vaccine Push With New Programs
05/20 09:14 am
Benzinga
Read morePulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
05/19 01:00 pm
GlobeNewswire Inc.
Read more